Editorial
Substantial advancements in Toxoplasma molecular and cell biology research have also occurred in the past 20 years. This issue includes three critical reviews and viewpoints on specific topics in those areas written by distinguished senior and young scientists who propose ideas that certainly will stimulate new directions for research for the next 100 years. In his article, Boothroyd explores the hypothesis that a combination of sexual recombination and host range expansion may be the major driving force in the evolution of some gene families and the specific genes they encompass. The author proposes central questions that remain to be investigated, such as: "Might some strains of Toxoplasma be adapted to sexual replication in non-feline hosts? How many strains have actually been tested for their ability to infect non-felines?" He concludes, stating: "Perhaps it is time to revisit the 'felines-only' dogma". Sullivan et al. discuss the evidence that shows how the clinically relevant process of bradyzoite differentiation is regulated at both transcriptional and post-transcriptional levels and pose some questions for future research. In the article entitled "What new cell biology findings could bring to therapeutics: is it time for a phenome project in Toxoplasma gondii?" Meissner and Klaus argue that in the absence of a powerful high-throughput technology for the characterization of essential genes of interests, a coordinated effort should be undertaken to convert the knowledge of the genome into that of the phenome.
The impact of the development on Toxoplasma genetics research can be evaluated in the articles presented in this issue by Jamielson et al., who tested the hypothesis that propensity for T. gondii to cause eye disease is associated with genes previously implicated in congenital or juvenile onset ocular disease, and by Dubey and Su, who compared Toxoplasma strains from United States and Brazil and concluded that different population structures of T. gondii between these countries may be shaped by different transmission routes. On the topics of molecular cell biology research and the host-parasite relationship, the articles published by Guimarães and Ferreira-da-Silva provide new data on the potential use of primary cultures of skeletal muscle cells as a cellular model for in vitro differentiation of the RH strain. Milovanović et al. present a set of data showing that significant lipid metabolism alterations, including a decrease in reverse cholesterol transport, are observed during acute Toxoplasma infection.
Substantial advances have also been achieved over the past 15 years in basic and applied research on the host immune response against Toxoplasma. Nine articles on this subject are published in the present issue. Five excellent reviews are presented. Hunter and Tait explore the development of a working model to study immunity to T. gondii, Garweg and Candolf discuss current facts and possible clues on the immunopathology of ocular toxoplasmosis and Subauste proposes that cell-mediated immunity through CD40 reroutes the parasitophorous vacuoles (PVs) to the lysosomal compartment by a process called autophagy, resulting in the death of T. gondii and thus challenging the dogma that the non-fusogenic nature of the PV is irreversible. Zaho et al. present a review on the immunity-related GTPase resistance system in mice. Schreiner and Liesenfeld present a review entitled "Small intestinal inflammation following oral infection with Toxoplasma gondii does not occur exclusively in C57BL/6 mice: review of 70 reports from the literature", in which the authors review the common features of small intestinal immunopathology in the animal kingdom and speculate on its consequences for immunopathology in humans. Two articles present data on the immune response of hosts. Brandão et al. report the immune response of experimental reinfection of BALB/c mice to different recombinant type I/III strains of T. gondii, and Bahia-Oliveira et al. describe the evidence for the role of cross-immunomodulation in the outcome of ocular toxoplasmosis in areas endemic for T. gondii and Ascaris lumbricoides. In the area of vaccinology, two reviews are presented. Innes et al. report some of the history, challenges and progress in the development of veterinary vaccines against T. gondii, Jongert et al. propose that future studies should use animal models other than rodents and that goals such as the prevention of maternal-foetal transmission and eye disease are as important as the traditional goals of survival or reduction in brain cyst numbers.
Environmental research on toxoplasmosis fortunately has gained even more importance. Three articles are presented on this subject: Villena et al. report methods for the detection of Toxoplasma oocysts in water and their application in the Champagne-Ardenne Region of France, Forman et al. describe the seroprevalence of T. gondii in British marine mammals and Mai et al. present an important review on oocyst wall formation and composition in coccidian parasites, factors that contribute to oocyst resistance to a variety of environmental and chemical insults.
Due to the effectiveness of sulphonamides against murine toxoplasmosis, reported by Sabin and Warren (1942) , and the synergistic effect of combined therapy with sulphonamides and pyrimethamine, described by Eyles and Coleman (1953) , these drugs form the basis for the standard therapy regimens for toxoplasmosis in humans (Remington et al. 2005) . However, more than 50 years after the first assays on drug management of toxoplasmosis, drug efficacy in the prevention of congenital toxoplasmosis and the treatment of ocular disease is still a matter for debate, as reported in five articles in this issue: (Chêne & Thiébaut, Gilbert, McLeod et al., Stanford & Gilbert and Peyron). Research on drugs should be one of the major goals of the next century, as emphasized in the presentations of several delegates at the meeting. This is the ultimate goal of cell biology studies, according to Sullivan et al. Development of a vaccine is another approach, both to reducing Toxoplasma burden in animals destined for meat production and to preventing human infection (Innes et al., Jongert et al.) .
We can only honour the legacy of the scientists awarded with the first edition of the Splendore and Nicolle Medal (see the foreword of this issue) on the progress of research in parasitology clinical management, diagnostics, immunology and molecular biology of T. gondii. Their works have directed efforts not only on the basic biology of the parasite but also in clinical management and public health areas of Toxoplasma research worldwide. In the field of public health, there are one review written by Tenter discussing the routes that are most important from a public health point of view, considering the transmission of the parasite to humans. It is also presented four articles in this issue with data from The Netherlands (Kortbeek et al.), Italy (Stagni et al.) and Brazil, where infection is a major health problem (Lopes et al., Varella et al.) . On the topic of diagnosis, articles are presented by Bessières et al., on congenital toxoplasmosis in France, by Neves et al., on acute acquired toxoplasmosis, and by Mesquita et al., on cerebral toxoplasmosis in peripheral blood samples from HIV-infected patients in Brazil. G Holland presents an article on clinical management of ocular disease entitled "Ocular toxoplasmosis: the influence of patient age", in which the author discusses the influence of patient age on ocular toxoplasmosis, concluding that it should be studied systematically in order to provide both a better understanding of disease mechanisms and clinical information that may be used to establish better treatment and prevention strategies. Comodaro et al. present an overview and update on ocular toxoplasmosis, addressing many misconceptions still found in the medical literature and Melamed presents a history of the ocular toxoplasmosis knowledge gained from studies and observations performed in Southern Brazil over the past 30 years.
Sadly, two months prior to the meeting held last September, Dr. George Desmonts, one of scientist who received the Splendore and Nicolle medal, died. However, his contribution to toxoplasmosis research is immortalised in the literature. One example is his and Jacques Couvreur's 1974 publication in the New England Journal of Medicine (Desmonts & Courvreur 1974) . This major publication revealed the importance of maternal-foetal transmission of T. gondii and its devastating consequences. This paper still remains a basic reference for anyone working on toxoplasmosis.
In our opinion, however, the major contribution by George Desmonts and his contemporary colleagues was their effort to have congenital toxoplasmosis included in the list of diseases that deserved special attention from the French public health authorities. The inclusion of congenital toxoplasmosis in such a list resulted in the establishment of a special programme to prevent, diagnose and treat congenital infections, an example to be followed by many countries.
The present issue of Memórias do Instituto Oswaldo Cruz is an homage not only to the pioneers Alfonso Splendore, Charles Nicolle and Luis Manceaux, but also to all the researchers and students who dedicated, continue to dedicate and shall dedicate their efforts to understanding the fascinating biology of this parasite and its relationships with hosts. This applies especially to those who have fought relentlessly to include toxoplasmosis, particularly congenital toxoplasmosis, in the list of diseases that are neglected and that deserve special attention from public health authorities worldwide, especially in places with alarming levels of infection. Finally, we extend this homage to toxoplasmosis victims, many of whom will never see or benefit from the success of these research efforts.
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